Cargando…

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients

Immunocompromised patients have a high risk of death from SARS-CoV-2 infection. Vaccination with an mRNA vaccine may protect these patients against severe COVID-19. Several studies have evaluated the impact of immune-suppressive drug regimens on cellular and humoral responses to SARS-CoV-2 variants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiedemann, Aurélie, Pellaton, Céline, Dekeyser, Manon, Guillaumat, Lydia, Déchenaud, Marie, Krief, Corinne, Lacabaratz, Christine, Grimbert, Philippe, Pantaleo, Giuseppe, Lévy, Yves, Durrbach, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441691/ https://www.ncbi.nlm.nih.gov/pubmed/36072955 http://dx.doi.org/10.3389/fmed.2022.978764

Ejemplares similares

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?
por: Dekeyser, Manon, et al.
Publicado: (2015)

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
por: Hocini, Hakim, et al.
Publicado: (2023)

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19
por: Hocini, Hakim, et al.
Publicado: (2023)

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation
por: Dekeyser, Manon, et al.
Publicado: (2022)

Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies
por: Gressens, Simon B., et al.
Publicado: (2023)

Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders
por: Perreau, Matthieu, et al.
Publicado: (2014)

Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection
por: Nikolova, Maria, et al.
Publicado: (2016)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017)

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
por: Lévy, Yves, et al.
Publicado: (2021)

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
por: Lévy, Yves, et al.
Publicado: (2022)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
por: Edwards, B. J., et al.
Publicado: (2011)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4(+)CD57(+) T Cells In Vivo and In Vitro
por: Herr, Florence, et al.
Publicado: (2023)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France
por: Mouelhi, Yosra, et al.
Publicado: (2018)

Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy
por: Morel, Antoine, et al.
Publicado: (2022)

(1078) The Antibody Response of an MMF-Containing Immunosuppressive Regimen Aftercovid-19 Vaccination in Asian Heart Transplant Recipient
por: Tsao, C., et al.
Publicado: (2023)

The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept
por: Snanoudj, Renaud, et al.
Publicado: (2007)

Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012)

Immune response to pertussis vaccine in COPD patients
por: Feredj, E., et al.
Publicado: (2023)

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial
por: Lévy, Y., et al.
Publicado: (2021)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
por: Tao, Jun, et al.
Publicado: (2021)

Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
por: Cillo, Umberto, et al.
Publicado: (2020)

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
por: Lévy, Yves, et al.
Publicado: (2020)

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells
por: Surenaud, Mathieu, et al.
Publicado: (2016)

Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
por: Cillo, Umberto, et al.
Publicado: (2021)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2022)

Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single‐center experience
por: Jáky‐Kováts, Zsuzsanna, et al.
Publicado: (2022)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2023)

BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient
por: Dao, Myriam, et al.
Publicado: (2018)

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
por: Zaza, Gianluigi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dv46dnatrethfki90mokjavnjs